UPDATE : Monday, September 7, 2020
상단여백
Price negotiations begin for breast cancer combo drugs
Drugmakers and the government will start talks this week to negotiate price...
by Kim Yun-mi  |  2020-03-25 16:25
라인
‘Outbreak will stop when 60% of Koreans become immune to COVID-19’
The ongoing spread of the new coronavirus (COVID-19) will stop when 60 perc...
by Kim Yun-mi  |  2020-03-24 16:19
라인
Study begins to compare 2 treatments for mild COVID-19 patients
A clinical study will begin in Korea soon to compare HIV drug Kaletra (ingr...
by Kim Yun-mi  |  2020-03-24 13:35
라인
Drug sales reps turning to digital promotions
The outbreak of the new coronavirus (COVID-19) has taken an extensive toll ...
by Kim Yun-mi  |  2020-03-23 16:15
라인
‘No evidence for hypertension drug’s harmful effect on COVID-19 patients’
Some studies recently raised concerns that angiotensin-converting enzyme (A...
by Kim Yun-mi  |  2020-03-18 16:48
라인
HIV combo drug Dovato scores local nod
GSK’s Dovato (ingredient: dolutegravir/lamivudine), the first two-drug regi...
by Kim Yun-mi  |  2020-03-17 15:58
라인
Medical group calls for reopening Gaeseong complex to make masks
The globe is suffering a massive shortage of face masks and protective gear...
by Kim Yun-mi  |  2020-03-12 17:07
라인
COVID-19 robs local cardiologists of chance to present inspiring research
Korean cardiologists won the ticket to present three investigator-initiated...
by Kim Yun-mi  |  2020-03-12 11:25
라인
45 COVID-19 test kits waiting for approval
Forty-two Korean companies have sought regulatory approval for 64 diagnosti...
by Kim Yun-mi  |  2020-03-11 14:12
라인
AbbVie’s Skyrizi expected to rock local psoriasis treatment market
AbbVie’s Skyrizi (ingredient: risankizumab), an interleukin-23 (IL-23) inhi...
by Kim Yun-mi  |  2020-03-11 11:29
라인
Astellas’ Xospata wins license for acute myeloid leukemia
The Ministry of Food and Drug Safety on Friday approved the marketing licen...
by Kim Yun-mi  |  2020-03-09 16:40
라인
295 Koreans to get remdesivir to fight COVID-19
The government has expanded the opportunity to test Gilead Sciences’ remdes...
by Kim Yun-mi  |  2020-03-09 11:05
라인
Takeda begins developing COVID-19 plasma therapy TAK-888
Takeda Pharmaceutical Company said it has started developing TAK-888, a pla...
by Kim Yun-mi  |  2020-03-06 14:35
라인
Smart patient monitoring system installed at KUMC’s coronavirus facility 
Korea University Medical Center has set up a smart patient monitoring syste...
by Kim Yun-mi  |  2020-03-05 15:46
라인
Korea nods testing remdesivir in COVID-19 patients
The Ministry of Food and Drug Safety said it has approved Gilead Sciences’ ...
by Kim Yun-mi  |  2020-03-04 13:46
라인
US firm to test potential coronavirus vaccine mRNA-1273
Gilead’s remdesivir is emerging as the first treatment of the new coronavir...
by Kim Yun-mi  |  2020-03-03 15:29
라인
‘S. Korea should pay attention to North’s coronavirus control’
“About 40 percent of the North Korean population is in poor nutrition. If a...
by Kim Yun-mi  |  2020-03-02 17:53
라인
US begins to test remdesivir for COVID-19 treatment
Following China, the U.S. has begun a clinical trial on remdesivir, Gilead’...
by Kim Yun-mi  |  2020-02-26 15:21
라인
Will Korean COVID-19 patients get to use remdesivir for compassionate use?
With new outbreaks of the novel coronavirus (COVID-19) spiked in Korea with...
by Kim Yun-mi  |  2020-02-24 17:41
라인
Labor group slams Fresenius for allegedly breaching labor law
The Korean offshoot of Germany-based Fresenius Medical Care has violated em...
by Kim Yun-mi  |  2020-02-21 16:39
-12345678910-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top